News brief

FTC Secures Major Settlement with Caremark, Resolving Antitrust Case Against Second Drug Middleman

AI

Summary: The Federal Trade Commission secured a settlement agreement with one of the nation’s largest pharmacy benefit managers (PBMs) and its affiliated entities, marking yet another important victory in the Commission’s fight to lower healthcare costs for Americans.Caremark Rx LLC and Zinc Health Services LLC (collectively Caremark) have agreed …

Why it matters: This matters if it changes how teams think about model governance, safety work, monitoring, or regulatory exposure around deployed AI systems.

What to watch: Watch for follow-on technical guidance, deployment constraints, evaluation details, or signs that the announcement changes actual production practice rather than just policy language.

Source: [Executive Risk] FTC Competition Press Releases